This may explain the synergistic effect of vincristine and L-asparaginase, in which vincristine may suppress the protective effect of MSCs in bone marrow to ALL blasts during L-asparaginase treatment. The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.